Phase I results of the randomized evaluation of left ventricular dysfunction (RESOLVD) trial

American Journal of Managed Care

Volumn 4, Issue 7 SUPPL., 1998, Pages

  Yusuf, Salim ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; ENALAPRIL; METOPROLOL;

ADULT; AGED; BLOOD PRESSURE; CLINICAL TRIAL; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART LEFT VENTRICLE; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WALKING;

EID: 0031826187     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. McKelvie R, Yusuf S, Wiecek E, et al. A trial of combination neurohormonal blockade with an ACE inhibitor, a β-blocker, and an angiotensin II-blocker in patients with congestive heart failure (CHF). In: Heart Failure 97 Second International Meeting organized under the auspices of the Working Group on Heart Failure. Cologne, Germany: European Society of Cardiology; 1997:42.
2. Tsuyuki, RT, Yusuf S, Rouleau JL, et al. Combination neurohormonal blockade with ACE inhibitors, angiotensin II antagonists and beta-blockers in patients with congestive heart failure: Design of the Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study. Can J Cardiol 1997:13;1166-1174.